{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:22:12Z","timestamp":1789428132320,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ygyno.2020.07.010","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T01:38:01Z","timestamp":1595036281000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer"],"prefix":"10.1016","volume":"159","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.07.010_bb0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0015","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0020","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0030","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0040","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e8","article-title":"A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma","volume":"30","author":"Takahashi","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2018.02.012","article-title":"Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer","volume":"149","author":"Matsuo","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0050","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e34","article-title":"Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy","volume":"29","author":"Tate","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.601","article-title":"Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database","volume":"218","author":"Seagle","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0060","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.03.011","article-title":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","volume":"145","author":"Scott","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/IGC.0000000000000072","article-title":"Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature","volume":"24","author":"Shiozaki","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3802\/jgo.2014.25.1.30","article-title":"FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype","volume":"25","author":"Haltia","year":"2014","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/AOG.0b013e3181a94568","article-title":"Stage IIIA endometrial carcinoma: outcome and predictors of survival","volume":"114","author":"Bansal","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10269-008-0898-z","article-title":"Positive peritoneal cytology and its prognostic value in endometrioid adenocancer confined to the uterus","volume":"10","author":"Metindir","year":"2008","journal-title":"Oncologie."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2006.03.003","article-title":"Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?","volume":"103","author":"Saga","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.bjc.6602035","article-title":"Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis","volume":"91","author":"Tebeu","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0115","author":"National Cancer Registrars Association"},{"issue":"Suppl. 23","key":"10.1016\/j.ygyno.2020.07.010_bb0125","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1002\/cncr.29054","article-title":"Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2","volume":"120","author":"Jamison","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0130","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.18632\/oncotarget.25550","article-title":"Trends and outcomes of women with synchronous endometrial and ovarian cancer","volume":"9","author":"Matsuo","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0135","author":"American Joint Committee on Cancer"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0140","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0145","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0150","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2012.41.6701","article-title":"Comparative effectiveness research in oncology methodology: observational data","volume":"30","author":"Hershman","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0155","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0160","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0165","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0170","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/annonc\/mdw161","article-title":"Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma","volume":"27","author":"Matsuo","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2015.08.014","article-title":"Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis","volume":"139","author":"Rauh-Hain","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2019.10.017","article-title":"Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers","volume":"156","author":"Mysona","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv158","article-title":"Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG oncology\/gynecologic oncology group 210 trial","volume":"107","author":"Felix","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2014.05.010","article-title":"Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer","volume":"134","author":"Han","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2017.03.017","article-title":"Surgical-pathological findings in type 1 and 2 endometrial cancer: an NRG Oncology\/Gynecologic Oncology Group study on GOG-210 protocol","volume":"145","author":"Creasman","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0200","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2011.07.1146","article-title":"Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis","volume":"96","author":"Chang","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/IGC.0b013e3181ca2290","article-title":"Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis","volume":"20","author":"Polyzos","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.010_bb0210","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.07.010_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2020.03.031","article-title":"Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer","volume":"133","author":"Matsuo","year":"2020","journal-title":"Eur. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:50:05Z","timestamp":1758772205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820323854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0090825820323854"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.07.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}